Understanding ILUMYA Prescribing Information: Dosage, Administration, and Side Effects
As of 2021, psoriasis affects an estimated 125 million people worldwide. Despite its prevalence, finding an effective treatment can be difficult. That’s where ILUMYA comes in.
ILUMYA is a prescription medicine used to treat adults with moderate-to-severe plaque psoriasis. It is an injection that delivers a specific type of antibody that binds to a protein called interleukin-23 (IL-23). This protein is believed to play a critical role in the development of psoriasis.
In this article, we will discuss ILUMYA’s prescribing information, including dosage, administration, and side effects.
Dosage
The recommended dose of ILUMYA is 100 mg injected subcutaneously every 12 weeks. Prior to prescribing ILUMYA, healthcare providers should evaluate patients for tuberculosis (TB) infection and consider testing for latent TB. In addition, patients should be tested for Hepatitis B virus (HBV) infection before starting treatment with ILUMYA.
Administration
ILUMYA is administered by subcutaneous injection in the upper arm, thigh, or abdomen. A healthcare professional can administer the injection or patients can learn how to self-inject with the help of their healthcare professional.
Before administering the injection, healthcare providers should provide patients with proper training on injecting techniques, as well as proper disposal of needles and syringes.
Side Effects
As with any medication, ILUMYA may cause side effects. The most common side effects seen in clinical trials included upper respiratory infections, injection site reactions, and diarrhea.
Other less common side effects that patients may experience include headache, fatigue, and nausea. In rare cases, ILUMYA may cause an allergic reaction.
It is important for patients to contact their healthcare provider if they experience any adverse reactions while taking ILUMYA.
Conclusion
ILUMYA is a promising treatment option for those with moderate-to-severe plaque psoriasis. By understanding its prescribing information, patients and healthcare providers can make informed decisions about whether or not ILUMYA is the right treatment option for them.
From dosage and administration to potential side effects, this article has provided a comprehensive overview of ILUMYA’s prescribing information. As always, patients should consult with their healthcare provider before starting any new medication.
(Note: Do you have knowledge or insights to share? Unlock new opportunities and expand your reach by joining our authors team. Click Registration to join us and share your expertise with our readers.)